DNA

Ginkgo Bioworks Holdings, Inc. $9.85 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+2.4%
Next 1 week
+1.8%
Next 1 month
+7.5%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Oversold — RSI(2) at 13
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.61%/day.
Mean-reversion stats →
1-month breakdown — Market · β 3.25 +7.6% · Seasonal tilt (4y) -0.2%
$38M/day volume 103% volatility -18% 1-year
52-week range · 35% of the way up · -46% from the high
$5.37$18.22

Earnings Full history →

Next report 2026-11-05 (Thursday, after close, in 2 days) · EPS est. -0.54.

1-day std dev
13.1%
Finished up
30%
Biggest pop
+22.7%
Biggest drop
-30.5%

Standard deviation of the close-to-close move over the last 20 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-05 miss -0.70 -0.73 -4.7% -2.6% -9.3% -22.7%
2026-05-07 miss -1.34 -1.39 -3.7% -16.2% -13.5% -25.3%
2026-02-26 beat -1.11 -0.77 +30.5% -17.5% -30.5% -33.1%
2025-11-06 miss -1.24 -1.45 -16.9% -8.9% -20.8% -28.9%
2025-08-07 beat -1.57 -1.10 +29.8% +4.4% -8.7% -2.1%
2025-05-06 beat -1.77 -1.68 +5.1% +5.9% +14.7% +21.4%
2025-02-25 beat -1.30 -1.21 +6.7% -14.3% -11.5% -19.7%
2024-11-12 beat -3.32 -1.08 +67.5% +8.3% +2.5% -24.2%
2024-08-08 miss -3.12 -4.40 -41.0% +8.4% -5.6% -22.4%
2024-05-09 beat -3.20 -2.87 +10.4% -13.4% -17.3% -12.4%
2024-02-29 miss -2.80 -2.94 -5.1% -15.8% -15.1% -19.7%
2023-11-08 miss -3.20 -3.65 -14.2% -6.7% -15.4% -2.0%
2023-08-09 beat -3.50 -3.06 +12.6% -4.5% -12.9% -19.9%
2023-05-10 beat -3.90 -3.89 +0.3% -7.4% -1.5% -2.2%
2023-03-01 beat -9.52 -3.29 +65.5% -2.9% +0.0% -10.7%
2022-11-14 miss -9.68 -16.51 -70.5% +1.1% -0.4% -25.4%
2022-08-15 miss -5.44 -16.44 -202.2% +19.5% +7.2% -22.9%
2022-05-16 miss -7.40 -14.80 -100.0% +4.9% +12.8% +6.2%
2022-03-28 miss -1.66 -42.00 -2434.5% +10.4% +22.7% -3.5%
2021-11-15 miss -1.40 -3.20 -128.6% +0.4% +0.5% +4.6%

Not investment advice.